MRK Earnings: Highlights of Merck’s Q1 2023 financial results
Pharma firm Merck & Co., Inc. (NYSE: MRK) on Thursday reported lower earnings for the first quarter of 2023, due to a sharp fall in revenues. First-quarter sales decreased 9% year-over-year […]
The post MRK Earnings: Highlights of Merck’s Q1 2023 financial results first appeared on AlphaStreet.